Rafael Holdings, Inc. (RFL)
1.23
+0.01
(+0.82%)
USD |
NYSE |
Dec 05, 16:00
1.22
-0.01
(-0.81%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 39.42M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -35.60% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 39.29 |
| Price to Book Value | 0.4176 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.0073 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 98.14% |
Profile
| Rafael Holdings, Inc. owns an interest in clinical and early-stage pharmaceutical companies. It operates through the following segments: Healthcare, Infusion Technology, and Real Estate. The Healthcare segment relates to the activities of LipoMedix, Barer, Farber, and Rafael Medical Devices. The Infusion Technology segment manages equity interest on Day Three. The Real Estate segment refers to the company’s real estate holdings. The company was founded in 2017 and is headquartered in Newark, NJ. |
| URL | http://www.rafaelholdings.com |
| Investor Relations URL | https://rafaelholdings.irpass.com/ |
| HQ State/Province | New Jersey |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Dec. 10, 2025 (est.) |
| Last Earnings Release | Jun. 12, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Rafael Holdings, Inc. owns an interest in clinical and early-stage pharmaceutical companies. It operates through the following segments: Healthcare, Infusion Technology, and Real Estate. The Healthcare segment relates to the activities of LipoMedix, Barer, Farber, and Rafael Medical Devices. The Infusion Technology segment manages equity interest on Day Three. The Real Estate segment refers to the company’s real estate holdings. The company was founded in 2017 and is headquartered in Newark, NJ. |
| URL | http://www.rafaelholdings.com |
| Investor Relations URL | https://rafaelholdings.irpass.com/ |
| HQ State/Province | New Jersey |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Dec. 10, 2025 (est.) |
| Last Earnings Release | Jun. 12, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |